Evidence and implications for early intervention in bipolar disorder

Journal of Mental Health

Volumn 19, Issue 2, 2010, Pages 113-126

  Berk, Michael ^a,b,c,e   Hallam, Karen ^a,f   Malhi, Gin S ^h,i   Henry, Lisa ^b   Hasty, Melissa ^b   MacNeil, Craig ^b   Yucel, Murat ^a,b,d   Pantelis, Chris ^a,d   Murphy, Brendan ^g   Vieta, Eduard ^j   Dodd, Seetal ^a,c   McGorry, Patrick D ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ORYGEN RESEARCH CENTRE   (Australia)

^c BARWON HEALTH   (Australia)

^d Melbourne Neuropsychiatry Centre   (Australia)

^e FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^f VICTORIA UNIVERSITY   (Australia)

^g MONASH UNIVERSITY   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ ROYAL NORTH SHORE HOSPITAL   (Australia)

^j UNIVERSITY OF BARCELONA   (Spain)

more..

Author keywords

Bipolar disorders; Diagnosis; Early intervention; Mania depression; Neuroprotection

Indexed keywords

BIPOLAR DISORDER; BRAIN; BRAIN SIZE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; EARLY DIAGNOSIS; HUMAN; MAJOR DEPRESSION; MEDICAL LITERATURE; MEDLINE; NEUROIMAGING; NEUROPROTECTION; PSYCHOTHERAPY; RECURRENT DISEASE; REVIEW; SCHIZOPHRENIA; THERAPY EFFECT;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN; COGNITION DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOLOGY; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 77950801509     PISSN: 09638237     EISSN: 13600567     Source Type: Journal    
DOI: 10.3109/09638230903469111     Document Type: Review

References (104)

1. Adler, C.M., DelBello, M.P., Jarvis, M.P., Levine, A., Adams, J., & Strakowski, S.M. (2007). Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biological Psychiatry, 61, 776-781.
2. Akiskal, H.S., Hantouche, E.G., Azorin, J.M., Lancrenon, S., Chatenet-Duchenne, L., & Alliare, J.F. (2003). Clinical characterisation of acute mania: Data in 1090 patients - 'EPIMAN-II'. Bipolar Disorders, 5(Suppl), 27.
3. Aliyazicioglu, R., Kural, B., Colak, M., Karahan, S.C., Ayvaz, S., & Deger, O. (2007). Treatment with lithium, alone or in combination with olanzapine, relieves oxidative stress but increases atherogenic lipids in bipolar disorder. Tohoku Journal of Experimental Medicine, 213(1), 79-87.
4. Altshuler, L.L., Post, R.M., Leverich, G.S., Mikalauskas, K., Rosoff, A., & Ackerman, L. (1995). Antidepressantinduced mania and cycle acceleration: A controversy revisited. American Journal of Psychiatry, 152(8), 1130-1138.
5. Altshuler, L.L., Suppes, T., Black, D.O., Nolen, W.A., Leverich, G.S., Keck, P.E., et al. (2006). Lower switch rates in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. American Journal of Psychiatry, 163, 313-315.
6. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders. (4th edn.). Washington, DC: APA.
7. Angst, J., Felder, W., & Lohmeyer, B. (1980). Course of schizoaffective psychoses: Results of a followup study. Schizophrenia Bulletin, 6(4), 579-585.
8. Atre-Vaidya, N., Taylor, M.A., Seidenberg, M., Reed, R., Perrine, A., & Glick-Oberwise, F. (1998). Cognitive deficits, psychopathology, and psychosocial functioning in bipolar mood disorder. Neuropsychiatry, Neuropsychology & Behavioural Neurology, 11, 120-126.
9. Baethege, C., Smolka, M.N., Grushka, P., Berghöfer, A., Schlattmann, P., Bauer, M., et al. (2003). Does prophylaxis-delay in bipolar disorder influence outcome? Results from a long-term study of 147 patients. Acta Psychiatrica Scandinavica, 107, 260-267.
10. Bai, O., Chlan-Fourney, J., Bowen, R., Keegan, D., & Li, X.M. (2003). Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. Journal of Neuroscience Research, 71(1), 127-131.
11. Bai, O., Zhang, H., & Li, X.M. (2004). Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Research, 1010(1-2), 81-86.
12. Baldessarini, R.J., Tondo, L., & Hennen, J. (2003). Treatment latency and previous episodes: Relationship to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disorder, 5, 169-179.
13. Bearden, C.E., Hoffman, K.M., & Cannon, T.D. (2001). The neuropsychology and neuroanatomy of bipolar affective disorder: A critical review. Bipolar Disorders, 3, 106-150.
14. Berk, M., & Dodd, S. (2005). Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression? Medical Hypotheses, 65, 39-43.
15. Berk, M., Dodd, S., Callaly, P., Berk, L., Fitzgerald, P., de Castella, A.R., et al. (2007). History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder. Journal of Affective Disorders, 103, 181-186.
16. Berk, M., Hallam, K., Lucas, N., Hasty, M., Macneil, C.A., Conus, P., et al. (2007). Early interventions in bipolar disorders: opportunities and pitfalls. Medical Journal of Australia, 187(Suppl 7), S11-S14.
17. Berk, M., Hallam, K.T., & McGorry, P.D. (2007). The potential utility of a staging model as a course specifier: A bipolar disorder perspective. Journal of Affective Disorders, 100, 279-280.
18. Berk,M., Malhi, G.S.,Mitchell, P.B., Cahill, C.M., Carman, A.C., Hadzi-Pavlovic, D., et al. (2004). Scale matters: the need for a Bipolar Depression Rating Scale (BDRS). Acta Psychiatrica Scandinavica, 110(Suppl 422), 39-45.
19. Blumberg, H.P., Leung, H.C., Skudlarski, P., et al. (2003). A functional magnetic resonance imaging study of bipolar disorder: State- and trait-related dysfunction in ventral prefrontal cortices. Archives of General Psychiatry, 60, 601-609.
20. Brady, K., & Goldberg, J.F. (1996). Substance abuse and bipolar disorder. Paper presented at the 9th Annual US Psychiatric and Mental Health Congress, 14-17 November.
21. Brambilla, P., Nicoletti,M.A., Harenski, K., Sassi, R.B., Mallinger, A.G., Frank, E., et al. (2002). Anatomical MRI study of subgenual prefrontal cortex in bipolar and unipolar subjects. Neuropsychopharmacology, 27(5), 792-799.
22. Cannon,M., Jones, P.,Gilvarry,C., Rifkin,L.,McKenzie,K., Foerster,A., et al. (1997). Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. American Journal of Psychiatry, 154(11), 1544-1550.
23. Chang, K., Karchemskiy, A., Barnea-Goraly, N., Garrett, A., Simeonova, D.I., & Reiss, A. (2005). Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. American Academy of Child and Adolescent Psychiatry, 44, 565-573.
24. Chen, G., Huang, L.D., Jiang, Y.M., & Manji, H.K. (1999). The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. Journal of Neurochemistry, 72, 1327-1330.
25. Colom, F. (2008). Long-term follow-up of psychotherapies in bipolar disorder. Bipolar Disorders, 10(Suppl.1), 20.
26. Conus, P., Cotton, S., Abdel-Baki, A., Lambert, M., Berk, M., & McGorry, P.D. (2006). Symptomatic and functional outcome 12 months after a first episode of psychotic mania: Barriers to recovery in a catchment are sample. Bipolar Disorder, 8(3), 221-231.
27. Conus, P., & McGorry, P.D. (2002). First-episode mania: A neglected priority for early intervention. Australian and New Zealand Journal of Psychiatry, 36(2), 158-172.
28. Correll, C.U., Penzner, J.B., Frederickson, A.M., Richter, J.J., Auther, A.M., Smith, C.W., et al. (2007). Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Schizophrenia Bulletin, 33(3), 703-714.
29. Decina, P., Kestenbaum, C.J., & Farber, S. (1983). Clinical and psychological assessment of children of bipolar probands. American Journal of Psychiatry, 140, 548-553.
30. Drevets, W.C., Ongur, D., & Price, J.L. (1998). Neuroimaging abnormalities in the subgenual prefrontal cortex: Implications for the pathophysiology of familial mood disorders. Molecular Psychiatry, 3(3), 220-226, 190-221.
31. Drevets, W.C., Price, J.L., Simpson, J.R., Jr., Todd, R.D., Reich, T., Vannier, M., et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature, 386(6627), 824-827.
32. Egeland, J.A., Hostetter, A.M., Pauls, D.L., & Sussex, J.N. (2000). Prodromal symptoms before onset of manicdepressive disorder suggested by first hospital admission histories. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 1245-1252.
33. El-Badri, S., Ashton, C., Moore, P., Marsh, V., & Ferrier, I. (2001). Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disorder, 3, 79-87.
34. Farrow, T.F., Whitford, T.J., Williams, L.M., Gomes, L., & Harris, A.W. (2005). Diagnosis-related regional grey matter loss over two years in first episode schizophrenia and bipolar disorder. Biological Psychiatry, 58, 713-723.
35. Foland, L.C., Altshuler, L.L., Bookheimer, S.Y., Eisenberger, N., Townsend, J., & Thompson, P.M. (2008). Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania. Psychiatry Research, 162(1), 27-37.
36. Fornito, A., Malhi, G., Lagopoulos, J., Ivanovski, B., Wood, S., Saling, M., et al. (2008). Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder. Psychiatry Research: Neuroimaging, 162(2), 123-132.
37. Franchini, L., Zanardi, R., Smeraldi, E., & Gasperini, M. (1999). Early onset of lithium prophylaxis as a predictor of good long-term outcome. European Archives of Psychiatry & Clinical Neuroscience, 249(5), 227-230.
38. Frazier, J.A., Breeze, J.L., Makris, N., Giuliano, A.S., Herbert, M.R., Seidman, L., et al. (2005). Cortical gray matter differences identified by structural magnetic resonance imaging in pediatric bipolar disorder. Bipolar Disorders, 7, 555-569. (Pubitemid 41830003)
39. Garner, B., Pariante, C.M., Wood, S., Velakoulis, D., et al. (2005). Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry, 58(5), 417-423.
40. Goldberg, J.F., & Ernst, C.L. (2002). Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. Journal of Clinical Psychiatry, 63, 985-991.
41. Goodwin, F.K., & Jamison, K.R. (2007). Manic-depressive illness: Bipolar disorder and recurrent depression (2nd edn.). New York: Oxford University Press.
42. Gould, T., D., Manji, H., K. (2005). Glycogen synthase kinase-3: A putative molecular target for lithium mimetic drugs. Neuropsychopharmacology, 30, 1223-1237.
43. Hantouche, E.G., & Akiskal, H.S. (2005). Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures. Journal of Affective Disorders, 84(2-3), 127-132.
44. Hawton, K., Sutton, L., Haw, C., Sinclair, J., & Harriss, L. (2005). Suicide and attempted suicide in bipolar disorder: A systematic review of risk factors. Journal of Clinical Psychiatry, 66, 693-704. (Pubitemid 40942414)
45. Jackson, H.J., Edwards, J., Hulbert, C., & McGorry, P.D. (1999). Recovery from psychosis: Psychological interventions. In P.D. McGorry & H.J. Jackson (Eds.), The recognition and management of early psychosis: A preventive approach. Cambridge, UK: Cambridge University Press.
46. Kapczinski, F., Vieta, E., Andreazza, A.C., et al. (2008). Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neuroscience & Biobehavioral Reviews, 32, 675-692.
47. Kessing, L.V., Andersen, P.K., & Mortensen, P.B. (1998). Predictors of recurrence in affective disorder: A case register study. Journal of Affective Disorders, 49, 101-108.
48. Klein, P.S., & Melton, D.A. (1996). A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of Sciences USA, 93(16), 8455-8459.
49. Konarski, J.Z., McIntyre, R.S., Kennedy, S.H., Rafi-Tari, S., Soczynska, J.K., & Ketter, T.A. (2008). Volumetric neuroimaging investigations in mood disorders: Bipolar disorder versus major depressive disorder. Bipolar Disorders, 10, 1-37.
50. Kraepelin, E. (2002). Lifetime editions of Kraepelin in English. (Vol. 5). Bristol: Thoemmes Press.
51. Leverich, G.S., Altshuler, L.L., Frye, M.A., Suppes, T., McElroy, S.L., Keck, P.E., Jr., et al. (2006). Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. American Journal of Psychiatry, 163(2), 232-239.
52. Lieberman, J.A., Tollefson, G.D., Charles, C., Zipursky, R., Sharma, T., Kahn, R.S., et al. (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry, 62, 361-370.
53. Lopez, C., Cortez, V., Palacio, C., Gallo, A., Lopera, J., & Garcia, J. (2008). Effects of chronicity on the cognitive performance of patients with bipolar disorder type 1. Bipolar Disorders, 10(Suppl. 1), 28.
54. Machado-Vieira, R., Andreazza, A.C., Viale, C.I., Zanatto, V., Cereser, V., Jr., da Silva Vargas, R., et al. (2007). Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects. Neuroscience Letters, 421(1), 33-36.
55. MacMaster, F.P., Leslie, R., Rosenberg, D.R., & Kusumakar, V. (2008). Pituitary gland volume in adolescent and young adult bipolar and unipolar depression. Bipolar Disorders, 10, 101-104.
56. Malhi, G., Ivanovski, B., Hadzi-Pavlovic, D., Mitchell, P.B., Vieta, E., & Sachdev, P. (2007). Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disorders, 9(1-2), 114-125.
57. Malhi, G.S., & Yatham, L.N. (2007). Mania matters! Acta Psychiatrica Scandinavica, 116(s434), 1-2.
58. Malhi, G.S., & Lagopoulos, J. (2008). Making sense of neuroimaging in psychiatry. Acta Psychiatrica Scandinavica, 117(2), 100-117.
59. Malhi, G.S., Valenzuela, M., Wen, W., & Sachdev, P. (2002). Magnetic resonance spectroscopy and its applications in psychiatry. Australian and New Zealand Journal of Psychiatry, 36, 31-43.
60. Manji, H.K., Moore, G.J., & Chen, G. (2001). Bipolar disorder: Leads from the molecular and cellular mechanisms of action of mood stabilisers. British Journal of Psychiatry, 178(Suppl. 41), 107-119.
61. Martinez-Ara, A., Vieta, E., & Colom, F. (2004). Cognitive impairment in euthymic bipolar patients: Implications for clinical and functional outcome. Bipolar Disorder, 6, 224-232.
62. Martinowich, K., Manji, H.K., & Lu, B. (2007). New perspective of BDNF cell biology and its implications in depression. Nature Neuroscience, 10, 1089-1093.
63. Matza, L.S., Rajagopalan, K.S., Thompson, C.L., & De Lissovoy, G. (2005). Misdiagnosed patients with bipolar disorder: Comorbidities, treatment patterns, and direct treatment costs. Journal of Clinical Psychiatry, 66, 1432-1440.
64. McGorry, P.D., Edwards, J., Mihalopoulos, C., Harrigan, S., & Jackson, H. (1996). EPPIC: An evolving system of early detection and optimal management. Schizophrenia Bulletin, 22(2), 305-326.
65. McGorry, P.D., Hickie, I.B., Yung, A.R., Pantelis, C., & Jackson, H.J. (2006). clinical staging of psychiatric disorders: A heuristic framework for choosing earlier, safer and more effective interventions. Australian and New Zealand Journal of Psychiatry, 40, 616-622.
66. McGorry, P.D., Hickie, I.B., Yung, A.R., Pantelis, C., & Jackson, H.J. (2006). Clinical staging of psychiatric disorders: A heuristic framework for choosing earlier, safer and more effective interventions. Australian and New Zealand Journal of Psychiatry, 40(8), 616-622.
67. Mitchell, P.B., & Malhi, G.S. (2004). Bipolar depression: Phenomenological overview and clinical characteristics. Bipolar Disorders, 6(6), 530-539.
68. Mitchell, P.B., Wilhelm, K., Parker, G., Austin, M.P., Rutgers, P., & Mahli, G.S. (2001). The clinical features of bipolar depression: A comparison with matched major depressive disorder patients. Journal of Clinical Psychiatry, 62, 212-216. (Pubitemid 32270103)
69. Monkul, E.S., Malhi, G.S., & Soares, J.C. (2005). Anatomical MRI abnormalities in bipolar disorder: do they exist and do they progress? Australian and New Zealand Journal of Psychiatry, 39, 222-226.
70. Moore, G.J., Bebchuk, J.M., Hasanat, K., Chen, G., Seraji-Bozorgzad, N., Wilds, I.B., et al. (2000). Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biological Psychiatry, 48(1), 1-8.
71. Moore, G.J., Bebchuk, J.M., Wilds, I.B., Chen, G., & Manji, H.K. (2000). Lithium-induced increase in human brain grey matter. Lancet, 356(9237), 1241-1242.
72. Nehra, R., Chakrabarti, S., Pradhan, B., & Khehra, N. (2006). Comparison of cognitive functions between firstand multi-episode bipolar affective disorders. Journal of Affective Disorders, 93(1-3), 185-192.
73. Ng, F., Berk, M., Dean, O., & Bush, A.I. (2008). Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. The International Journal of Neuropsychopharmacology, 11, 851-876.
74. Perugi, G., Micheli, C., Akiskal, H.S., Madaro, D., Socci, C., Quilici, C., et al. (2000). Polarity of the first episode, clinical characteristics, and course of manic depressive illness: A systematic retrospective investigation of 320 bipolar I patients. Comprehensive Psychiatry, 41(1), 13-18.
75. Post, R.M. (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. American Journal of Psychiatry, 149, 999-1010.
76. Post, R.M., Altshuler, L., Frye, M.A., Suppes, T., Rush, A.J., Keck, P.E., et al. (2001). Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disorders, 3, 259-265.
77. Post, R.M., Leverich, G.S., Altshuler, L., Frye, M.A., Suppes, T.M., Keck, P.E., et al. (2003). An overview of recent findings of the Stanley Foundation bipolar Network (Part 1). Bipolar Disorders, 5, 310-319.
78. Robinson, L.J., & Ferrier, N. (2006). Evolution of cognitive impairment in bipolar disorder: A systematic review of cross-sectional evidence. Bipolar Disorders, 8(2), 103-116.
79. Roy-Byrne, P., Post, R.M., Uhde, T.W., Porcu, T., & Davis, D. (1985). The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatrica Scandinavica, Supplementum, 317, 1-34.
80. Sassi, R.B., Brambilla, P., Hatch, J.P., Nicoletti, M.A., Mallinger, A.G., Frank, E., et al. (2004). Reduced left anterior cingulate volumes in untreated bipolar patients. Biological Psychiatry, 56(7), 467-475.
81. Scherk, H., Kemmer, C., Usher, J., Reith, W., Falkai, P., & Gruber, O. (2008). No change to grey and white matter volumes in bipolar I disorder patients. European Archives of Psychiatry & Clinical Neuroscience, 258, 345-349.
82. Schulze, T.G., Muller, D.J., Krauss, H., Gross, M., Fangerau-Lefevre, H., Illes, F., et al. (2002). Further evidence for age of onset being an indicator for severity in bipolar disorder. Journal of Affective Disorders, 68, 343-345.
83. Scott, J. (1995). Psychotherapy for bipolar disorder. British Journal of Psychiatry, 167(5), 581-588.
84. Scott, J., Paykel, E., Morriss, R., Bentall, R., Kinderman, P., Johnson, T., et al. (2006). Cognitive-behavioural therapy for severe and recurrent bipolar disorders: Randomised controlled trial. British Journal of Psychiatry, 188, 313-320.
85. Sharma, V., & Mazmanian, D. (2003). Sleep loss and postpartum psychosis. Bipolar Disorders, 5(2), 98-105.
86. Sharma, V., Menon, R., Carr, T.J., Densmore, M., Mazmanian, D., & Williamson, P.C. (2003). An MRI study of subgenual prefrontal cortex in patients with familial and non-familial bipolar I disorder. Journal of Affective Disorders, 77(2), 167-171.
87. Silva, R., Martins, L., Longatto-Filho, A., Almeida, O.F., & Sousa, N. (2007). Lithium prevents stress-induced reduction of vascular endothelium growth factor levels. Neuroscience Letters, 429(1), 33-38.
88. Silva, R., Mesquita, A.R., Bessa, J., Sousa, J.C., Sotiropoulos, I., Leao, P., et al. (2008). Lithium blocks stressinduced changes in depressive-like behavior and hippocampal cell fate: The role of glycogen-synthase-kinase-3beta. Neuroscience, 152(3), 656-669.
89. Singh, M.K., Del Bello, M.P., Stanford, K.E., Soutullo, C., McDonough-Ryan, P., McElroy, S.L., et al. (2007). Psychopathology in children of bipolar parents. Journal of Affective Disorders, 102, 131-136.
90. Stork, C., & Renshaw, P.F. (2005). Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry, 10(10), 900-919.
91. Strakowski, S.M., Keck, P.E., McElroy, S.L., West, S.A., Sax, K.W., Hawkins, J.M., et al. (1998). Twelve-month outcome after first hospitalisation for affective psychosis. Archives of General Psychiatry, 55, 49-55.
92. Strakowski, S.M., Williams, J.R., Fleck, D.E., & Delbello, M.P. (2000). Eight-month functional outcome from mania following a first psychiatric hospitalization. Journal of Psychiatric Research, 34(3), 193-200.
93. Sullivan, R.M., & Gratton, A. (1999). Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress responses in rats. Journal of Neuroscience, 19(7), 2834-2840.
94. Swann, A.C., Bowden, C.L., Calabrese, J.R., Dilsaver, S.C., & Morris, D.D. (1999). Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in mania. American Journal of Psychiatry, 156, 1264-1266.
95. Tohen, M., Hennen, J., Zarate, C.M., Jr., Baldessarini, R.J., Strakowski, S.M., Stoll, A.L., et al. (2000). Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. American Journal of Psychiatry, 157(2), 220-228.
96. Velakoulis, D., Pantelis, C., McGorry, P.D., Dudgeon, P., Brewer, W., Cook, M., et al. (1999). Hippocampal volume in first-episode psychoses and chronic schizophrenia: A high-resolution magnetic resonance imaging study. Archives of General Psychiatry, 56(2), 133-141.
97. Velakoulis, D., Wood, S., Wong,M.T., McGorry, P., Yung, A., Phillips, L., et al. (2006). Hippocampal and amygdala volumes according to psychosis stage and diagnosis: A magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Archives of General Psychiatry, 63, 139-149.
98. Waters, B., & Calleia, S. (1983). The effect of juvenile-onset manic-depressive disorder on the developmental tasks of adolescence. American Journal of Psychotherapy, 37(2), 182-189.
99. Winters, K.C., Stone, A.A., Weintraub, S., & Neale, J.M. (1981). Cognitive and attentional deficits in children vulnerable to psychopathology. Journal of Abnormal Child Psychology, 9, 435-453.
100. World Health Organization. (2005). International Statistical Classification of Diseases and Related Health Problems (The) ICD-10 (2nd edn). Nonserial Publications.
101. Wozniak, J., Biederman, J., & Richards, J.A. (2001). Diagnostic and therapeutic dilemmas in the management of pedistric-onset bipolar disorder. Journal of Clinical Psychiatry, 62(Suppl 14), 10-15.
102. Zarate, C.A.J., & Tohen, M. (2000). Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. Journal of Clinical Psychiatry, 61, 33-38.
103. Zimmerman, M.E., DelBello, M.P., Getz, G.E., Shear, P.K., & Strakowski, S.M. (2006). Anterior cingulate subregion volumes and executive function in bipolar disorder. Bipolar Disorders, 8(3), 281-288.
104. Zis, A.P., Grof, P., Webster, M., et al. (1980). Prediction of relapse in recurrent affective disorder. Psychopharmacology Bulletin, 16, 47-49.